Optimizing insulin therapy in pregnant women with type 1 diabetes mellitus

Treatments in Endocrinology

Volumn 1, Issue 4, 2002, Pages 235-240

  Gottlieb, Peter A ^a,b   Frias, Juan P ^a,b   Peters, Kelly A ^b   Chillara, Bhavani ^a,b   Garg, Satish K ^a,b  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF COLORADO DENVER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; INSULIN ASPART; INSULIN LISPRO;

BLOOD GLUCOSE MONITORING; CONGENITAL MALFORMATION; DOSE RESPONSE; DRUG ABSORPTION; DRUG SAFETY; DRUG USE; FEMALE; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN PUMP; INSULIN TREATMENT; LIFESTYLE; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; RETINOPATHY; REVIEW;

DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; INSULIN; LABOR, OBSTETRIC; POSTPARTUM PERIOD; PRECONCEPTION CARE; PREGNANCY; PREGNANCY IN DIABETICS;

EID: 0038684174     PISSN: 11756349     EISSN: None     Source Type: Journal    
DOI: 10.2165/00024677-200201040-00005     Document Type: Review

References (49)

1. Healy K, Jovanovic-Peterson L, Peterson CM. Pancreatic disorders of pregnancy: pregestational diabetes. Endocrinol Metab Clin North Am 1995; 24: 73-101
2. Langer O, Conway DL. Level of glycemia and perinatal outcome in pregestational diabetes. J Matern Fetal Med 2000; 9: 35-41
3. McElvy SS, Miodovnik M, Rosenn B, et al. A focused preconceptional and early pregnancy program in women with type 1 diabetes reduces perinatal mortality and malformation rates to general population levels. J Matern Fetal Med 2000; 9: 14-20
4. Jovanovic-Peterson L, Peterson CM, Reed GF, et al. National Institute of Child Health and Human Development - Diabetes in Early Pregnancy Study. Maternal postprandial glucose levels and infant birth weight: the diabetes in early pregnancy study. Am J Obstet Gynecol 1991; 164: 103-11
5. Combs CA, Gunderson E, Kitzmiller JL, et al. Relationship of fetal macrosomia to maternal postprandial glucose control during pregnancy. Diabetes Care 1992; 15: 1251-7
6. de Veciana M, Major CA, Morgan MA, et al. Postprandial versus preprandial blood glucose monitoring in women with gestational diabetes mellitus requiring insulin therapy. N Engl J Med 1995; 333: 1237-41
7. Vajo Z, Duckworth WC. Genetically engineered insulin analogs: diabetes in the new millenium. Pharmacol Rev 2000; 52: 1-9
8. Rosenn B, Miodovnik M, Combs CA, et al. Pre-conception management of insulin-dependent diabetes: improvement of pregnancy outcome. Obstet Gynecol 1991; 77: 846-9
9. Goldman JA, Dicker D, Feldberg D, et al. Pregnancy outcome in patients with insulin-dependent diabetes mellitus with preconception diabetic control: a comparative study. Am J Obstet Gynecol 1986; 155: 293-7
10. Holing EV, Beyer CS, Brown ZA, et al. Why don't women with diabetes plan their pregnancies? Diabetes Care 1988; 21: 889-95
11. Franz MJ, Bantle JP, Beebe CA, et al. Evidence-based nutrition principles and recommendations for the treatment and prevention of diabetes and related complications (technical review). Diabetes Care 2002; 25: S136-8
12. Miodovnik M, Mimouni F, Tsang RC, et al. Elevated maternal glycohemoglobin in early pregnancy and spontaneous abortion among insulin-dependent diabetic women. Am J Obstet Gynecol 1985; 153: 439-42
13. Kitzmiller JL, Buchanan TA, Kjos S, et al. Pre-conception care of diabetes, congenital malformation, and spontaneous abortions. Diabetes Care 1996; 19: 514-41
14. Kitzmiller JL, Gavin LA, Gin GD, et al. Preconception care of diabetes: glycemic control prevents congenital anomalies. JAMA 1991; 265: 731-6
15. Diamond MP, Reece EA, Caprio S, et al. Impairment of counterregulatory hormone responses to hypoglycemia in pregnant women with insulin-dependent diabetes mellitus. Am J Obstet Gynecol 1992; 166: 70-7
16. Rosenn BM, Miodovnik M, Khoury JC, et al. Counterregulatory hormonal responses to hypoglycemia during pregnancy. Obstet Gynecol 1996; 87: 568-74
17. Rosenn BM, Miodovnik M, Holcberg G, et al. Hypoglycemia: the price of intensive insulin therapy for pregnant women with insulin-dependent diabetes mellitus. Obstet Gynecol 1995; 85: 417-22
18. Rosenn GM, Miodovnik M. Glycemic control in the diabetic pregnancy: is tighter always better? J Matern-Fetal Med 2000; 9: 29-34
19. Ter Braak EW, Evers IM, Willem Erkelens D, et al. Maternal hypoglycemia during pregnancy in type 1 diabetes: maternal and fetal consequences. Diabetes Metab Res Rev 2002 Mar-Apr; 18 (2): 96-105
20. Jovanovic L, editor. Medical management of pregnancy complicated by diabetes. 3rd ed. Alexandria (VA): American Diabetes Association, 2000
21. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977-86
22. Gabbe SG, Holing E, Temple P, et al. Benefits, risks, costs, and patient satisfaction associated with insulin pump therapy for the pregnancy complicated by type 1 diabetes mellitus. Am J Obstet Gynecol 2000; 182: 1283-91
23. Lenhard MJ. Reeves GD. Continuous subcutaneous insulin infusion: a comprehensive review of insulin pump therapy. Arch Intern Med 2001; 161 (9): 2293-300
24. Gabbe SG. New concepts and applications in the use of the insulin pump during pregnancy. J Matern Fetal Med 2000; 9: 42-5
25. Heinemann L, Woodworth J. Pharmacokinetics and glucodynamics of insulin lispro. Drugs Today 1998; 34 Suppl. 3: 23-36
26. Home PD, Barriocanal L, Lindholm A. Comparative pharmacokinetics and pharmacodynamics of the novel rapid-acting insulin analogue, insulin aspart, in healthy volunteers. Eur J Clin Pharmacol 1999; 55: 199-203
27. Home PD, Lindholm A, Hylleberg B, et al. Improved glycemic control with insulin aspart: a multicenter randomized double-blind crossover trial in type 1 diabetic patients. UK Insulin Aspart Study Group. Diabetes Care 1998; 21: 1904-9
28. Anderson JH, Koivisto VA. Clinical studies on insulin lispro. Drugs Today 1998; 34 Suppl. C: 37-50
29. Anderson JH, Brunelle RL, Koivisto VA, et al. Reduction of postprandial hyperglycemia and frequency of hypoglycemia in IDDM patients in insulin-analog treatment. Diabetes 1997; 46: 265-70
30. Zinman B, Tildesley H, Chiasson J-L, et al. Insulin lispro in CSII: results of a double-blind crossover study. Diabetes 1997; 46: 440-3
31. Lalli C, Ciofetta M, Del Sindaco P, et al. Long-term intensive treatment of type 1 diabetes with the short-acting insulin analog lispro in variable combination with NPH insulin at mealtime. Diabetes Care 1999; 22: 468-77
32. Ebeling P, Jansson P-A, Smith U, et al. Strategies towards improved control during insulin lispro therapy in IDDM: importance of basal insulin. Diabetes Care 1997; 20: 1287-9
33. Diamond T, Kormas N. Possible adverse fetal effect of insulin lispro. N Engl J Med 1997; 337: 1009-10
34. Kitzmiller JL, Main E, Ward B, et al. Insulin lispro and the development of proliferative diabetic retinopathy during pregnancy. Diabetes Care 1999; 22: 874-6
35. Jovanovic L, Ilic S, Pettitt DJ, et al. Metabolic and immunological effects of insulin lispro in gestational diabetes. Diabetes Care 1999; 22: 1422-7
36. Bhattacharyya A, Vice PA. Insulin lispro, pregnancy, and retinopathy. Diabetes Care 1999; 22: 2101-2
37. Bhattacharyya A, Brown S, Hughes S, et al. Insulin lispro and regular insulin in pregnancy. QJM 2001; 94: 255-60
38. Buchbinder A, Miodovnik M, McElvy S, et al. Is insulin lispro associated with the development or progression of diabetic retinopathy during pregnancy? Am J Obstet Gynecol 2000; 183: 1162-5
39. Garg SK, Anil S, Gottlieb P, et al. Better glycemic control and reduced need for caesarian sections with insulin lispro treated pregnancies in type 1 diabetes [abstract]. Diabetes 2001; 50 Suppl. 2: A383
40. Jovanovic L. Retinopathy risk: what is responsible? Hormones, hyperglycemia, or Humalog? Diabetes Care 1999; 22: 846-7
41. Brunelle RL, Llewelyn J, Anderson Jr JH, et al. Meta-analysis of the effect of insulin lispro on severe hypoglycemia in patients with type 1 diabetes. Diabetes Care 1998; 21: 1726-31
42. Rassmusen SA, Moore CA, Paulozzi LJ, et al. Risk for birth defects among premature infants: a population-based study. J Pediatr 2001; 138: 668-73
43. Montgomery A, Miller L. Using the Colorado birth defects monitoring program to connect families with services for children with special needs. Teratology 2001; 64: S42-6
44. Horton Jr WE, Sadler TW. Effects of maternal diabetes on early embryogenesis: alterations in morphogenesis produced by the ketone body, B-hydroxybutyrate. Diabetes 1983; 32: 610-6
45. Jovanovic L, Knopp RH, Brown Z, et al. Declining insulin requirements in the late first trimester of diabetic pregnancy. Diabetes Care 2001; 24: 1130-6
46. Reece EA, Homko CJ. Diabetes mellitus in pregnancy: what are the best treatment options? Drug Saf 1998; 18 (3): 209-20
47. Jovanovic L, Peterson CM. Insulin and glucose requirements during the first stage of labor in insulin-dependent diabetic women. Am J Med 1983; 75: 607-12
48. Jovanovic L, Peterson CM. Optimal insulin delivery for the pregnant diabetic patient. Diabetes Care 1982; 5 Suppl. 1: 24-37
49. Garg S, Susaria K, Jackson W, et al. Insulin lispro (Humalog®) and the renal and retinal complications of type 1 diabetes [abstract]. Diabetologia 1997; 40: 501